Open Access@KRIBBDivision of A.I. & Biomedical ResearchImmunotherapy Research Center3. Research Reports
항암 CAR-면역세포치료제의 고도화 플랫폼 개발
Cited 0 time in 
Metadata Downloads
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김태돈 | - |
| dc.contributor.author | 이수연 | - |
| dc.contributor.author | 오세찬 | - |
| dc.contributor.author | 김석민 | - |
| dc.contributor.author | 장인환 | - |
| dc.contributor.author | 서지연 | - |
| dc.contributor.author | 김지현 | - |
| dc.coverage.temporal | 20230501-20231231 | - |
| dc.date.accessioned | 2024-01-18T16:32:55Z | - |
| dc.date.available | 2024-01-18T16:32:55Z | - |
| dc.date.issued | 2023-11-08 | - |
| dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/33382 | - |
| dc.format.extent | 25 | - |
| dc.publisher | 과학기술정보통신부 | - |
| dc.title | 항암 CAR-면역세포치료제의 고도화 플랫폼 개발 | - |
| dc.title.alternative | Platform development of optimized CAR-immune cell therapy | - |
| dc.type | Report | - |
| dc.contributor.affiliatedAuthor | 김태돈 | - |
| dc.contributor.affiliatedAuthor | 이수연 | - |
| dc.contributor.affiliatedAuthor | 오세찬 | - |
| dc.contributor.affiliatedAuthor | 김석민 | - |
| dc.contributor.affiliatedAuthor | 장인환 | - |
| dc.contributor.affiliatedAuthor | 서지연 | - |
| dc.contributor.affiliatedAuthor | 김지현 | - |
| dc.contributor.alternativeName | Tae-Don Kim | - |
| dc.contributor.alternativeName | Sooyun Lee | - |
| dc.contributor.alternativeName | Se-Chan Oh | - |
| dc.contributor.alternativeName | Seok-Min Kim | - |
| dc.contributor.alternativeName | Jang In Hwan | - |
| dc.contributor.alternativeName | Seo Ji Yeon | - |
| dc.contributor.alternativeName | Kim Ji Hyun | - |
| dc.identifier.ndsl | TRKO202400000156 | - |
| dc.description.sponsorshipAwardTitle | 항암 CAR-면역세포치료제의 고도화 플랫폼 개발 | - |
| dc.contributor.director | 김태돈 | - |
- Appears in Collections:
- Division of A.I. & Biomedical Research > Immunotherapy Research Center > 3. Research Reports
- Files in This Item:
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.